Biomedical subjects

V Huber-Spitzy

Publications and source records attributed to V Huber-Spitzy.

43 records · Page 3Linked to original sources

PubMed1985

[Clinical aspects, diagnosis and therapy of ocular Chlamydia infection].

As reported in the recent literature, eye infections caused by Chlamydia trachomatis are increasing in number. Modern laboratory techniques were used in this study to scan a total of 114 patients with unilateral follicular conjunctivitis for these organisms. The authors describe the clinical picture, course, and results of therapy in a total of 6 (5.3%) young patients with chlamydial infections diagnosed by scraping and cell culture.

Administration, Topical↗

PubMed1985

[Human corneal fibroblasts and a human conjunctival cell line (Chang) produce a thymocyte-activating factor (TAF) in vitro].

A variety of distinct cells such as fibroblasts, epidermal cells, glioblastoma cells and corneal epithelial cells have been shown to produce Interleukin 1-like thymocyte-activating factors. Under in vitro conditions these cytokines influence a multiplicity of different cell types, including lymphocytes, fibroblasts, PMN and hepatocytes. In the present study human corneal fibroblasts, as well as the human epitheloid conjunctival Chang cell line were found to produce thymocyte-activating factors (TAF). The molecular weight of the corneal fibroblasts-TAF was found in the 670 kD region, with minor peaks of activity at 30, 17 and 4 kD. TAF from the Chang-cell line eluted at 15-25 kD. Chromatofocusing revealed the pI of the fibroblast-TAF to be at 6.7 and 5.2 and the pI of the conjunctival cells to be at 7.0, 5.3 and 5.0. The latter cells produced prostaglandin E2 upon stimulation. The immunomodulating properties of these cytokines make an important in vivo role in the pathogenesis of inflammatory corneal and conjunctival diseases probable.

Biological Products↗

PubMed1985

[Corneal epithelial cells and human conjunctival cell line (Chang) produce an interleukin 3-like factor].

Tissue mast cells play a central role in the pathogenesis of allergic eye diseases. In the study reported here the authors investigated whether human corneal epithelial cells and a human epitheloid conjunctival cell line (Chang) can produce an interleukin 3 (IL 3)-like mast cell-activating factor. The activity was detected at a m.w. of 15 and 30 kD, the isoelectric points were located at a pH of 7.85, 7.15 and 6.75. The authors believe that this cytokine, which is produced by epithelial cells of the cornea and conjunctiva, might play an important role in the pathogenesis of allergic ocular diseases.

Cell Line↗

PubMed1984

[Syndrome of the flaccid eyelid (floppy eyelid syndrome].

Three patients with increasing swelling of the lateral half of the upper lid associated with chronic papillary conjunctivitis which did not respond to therapy were observed. The history, clinical findings, keratinized epithelial cells in the scrapings and the therapeutic success with a protective shield over night suggested the diagnosis of floppy eyelid syndrome.

Chronic Disease↗

PubMedDate not supplied

Diagnosis and therapy of bacterial endophthalmitis, and serum levels of inflammation markers.

A review of 27 cases of bacterial endophthalmitis diagnosed and treated at the Specialized Outpatient Department for Infectious Eye Diseases at the 2nd Department of Ophthalmology of the University of Vienna over a period of eight years (January 1983-April 1991) is presented. In 70% of the cases the patients had undergone surgical intervention. Conjunctival samples were routinely taken for microbiological investigations (aerobic as well as anaerobic cultures). In 19 patients (70.4%) aqueous specimens were obtained, in 22 cases (81.5%) vitreous specimens collected during vitrectomy for the removal of infected material were used for microbiological diagnosis. The results for the patient population described showed the poor reliability of conjunctival cultures from intraocular infections with only 36.84% being identical with those of the vitreous specimens. In the most recent 11 patients three serological parameters of inflammation were tested on various occasions: C-reactive protein, PMN- elastase and light immunoglobulin chain assembling (kappa/lambda). Clinical results, microbiological findings and therapeutic approaches are presented and discussed.

Adult↗

PubMedDate not supplied

In vitro susceptibilities to topical antibiotics of bacteria isolated from the surface of clinically symptomatic eyes.

BACKGROUND: The permanent change of resistance patterns of bacteria causing ocular infections makes repeat susceptibility testings against the most recent clinical isolates mandatory. The aim of the present study was to assess the in vitro susceptibility of ocular bacterial isolates of clinically symptomatic eyes admitted to the outpatient clinic of the eye department of a large central hospital to commonly used topical antibiotics. METHODS: Ocular isolates (n = 454) were tested for their susceptibility to ofloxacin, ciprofloxacin, norfloxacin, gentamicin, tobramycin, meomycin, bacitracin, erythromycin, tetracycline and chloramphenicol. RESULTS: All three tested fluoroquinolones were found to be very effective against gram-negative organisms but demonstrated some weakness against certain strains of gram-positive germs, in particular coagulase-negative staphylococci and Streptococcus viridans. These germs, however, were very susceptible to bacitracin and chloramphenicol. The relative overall in vitro efficacy was (in decreasing order): chloramphenicol, ciprofloxacin, ofloxacin, norfloxacin, bacitracin, tetracycline, neomycin, erythromycin, tobramycin and gentamicin. CONCLUSION: Chloramphenicol had the highest overall in vitro efficacy, but has potential lethal side effects. The fluoroquinolones were highly effective, especially being superior to the aminoglycosides tested, but no single antibiotic provided 100% coverage against all of the bacterial isolates that were tested.

Aminoglycosides↗

PubMedDate not supplied

Efficacy of norfloxacin in bacterial conjunctivitis.

We investigated the efficacy and safety of norfloxacin 0.3% ophthalmic solution in 120 patients with bacterial conjunctivitis or blepharitis. Patients were selected for the study if they showed conjunctival hyperemia and at least three of the following criteria: a) symptoms of a surface ocular infection; b) a purulent discharge; c) crusting of the eyelids, and d) thickened, red lid margins. After taking a specimen for culture from the conjunctiva or skin-lash margin, the test drug was administered to the infected eye every two hours for one day, then 4 times daily for one week. Of the 120 patients who entered the study, 84.1% were cured. No serious adverse reactions occurred.

Adolescent↗